Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOVELTY: Ticagrelor vs Clopidogrel in CAD
NCT02071212Phase 2Completed
- Sponsor
- Hellenic Cardiovascular Research Society
- Start
- Feb 2014
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of ticagrelor in coronary artery disease (CAD) (2 arms), sponsored by Hellenic Cardiovascular Research Society. Primary endpoint: Carotid-femoral Pulse Wave Velocity at 3 hours. Started Feb 2014; status: completed.
02
Drugs
ticagrelor
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02071212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02071212.